Medicine & Health

A new study from the School of Medicine finds that African American children with mild asthma can take their steroid inhalers as needed, based on symptoms, rather than at set times daily regardless of symptoms.

A study of the genetics of the people of Finland, conducted in part by researchers at the School of Medicine, has revealed new clues to common diseases.

Researchers at the School of Medicine and the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh, are developing a new approach to address childhood malnutrition. They are designing therapeutic foods aimed at repairing the gut microbiomes of malnourished children.

Researchers at the School of Medicine in St. Louis and Rush University in Chicago have found a compound that promotes a vigorous immune assault on pancreatic cancer. The findings, in mice, suggest a way to improve immunotherapy for the deadly disease in patients.

Studying children shortly after they began experiencing tics, researchers at the School of Medicine discovered that although tics don’t go away, most children are able to suppress and control them. Understanding how they do that may provide insight to help others at risk for significant tic disorders.

School of Medicine researchers have figured out how to grow the intestinal parasite Cryptosporidium in the lab, an achievement that will speed efforts to treat or prevent diarrhea caused by the parasite.

Researchers at the School of Medicine and the Africa Health Research Institute have identified a master cell that coordinates the body’s immune defenses in the crucial early days after a tuberculosis infection. Boosting the activity of such cells could help reduce the millions of new infections that occur worldwide every year.

A study from researchers at the School of Medicine and Veterans Affairs St. Louis Health Care System has linked long-term use of drugs known as proton pump inhibitors (PPIs) to fatal cases of cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer. The researchers found that such risks increase with the duration of PPI use, even when taken at low doses.

Researchers at the School of Medicine studying brain tumors in mice discovered that tumors grow most rapidly if they can enlist the aid of immune cells. The findings suggest that therapies targeting immune cells could potentially treat some kinds of brain tumors.

A new study led by the School of Medicine has found that proton therapy is associated with fewer severe side effects than conventional X-ray radiation therapy for many cancer patients.